Skip to main content
. 2020 Sep 20;18(9):478. doi: 10.3390/md18090478

Table 2.

Absorption, Distribution, Metabolism, and Excretion (ADME) parameters related to the theopapuamides A-D pharmacokinetics.

Theopapuamides
A B C D
GI absorption Low Low Low Low
BBB permeable No No No No
P-gp substrate Yes Yes Yes Yes
CYP1A2 inhibitor No No No No
CYP2C19 inhibitor No No No No
CYP2C9 inhibitor No No No No
CYP2D6 inhibitor No No No No
CYP3A4 inhibitor No No No No
Log Kp (skin permeation) −19.30 −19.37 −18.28 −17.98
(cm/s)